Pulse Therapeutics, Inc. — Form D
Pulse Therapeutics, Inc. of ST. LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2014-02-06. The offering totals $1.5M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-02-06
- Form: D
- Accession: 0001518707-14-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $1.0M
- Remaining: $475K
- Minimum investment: $25K
- Investors: 3
- Date of first sale: 2013-12-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-211425
Issuer
- Name: Pulse Therapeutics, Inc.
- CIK: 0001518707
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 911 WASHINGTON AVENUE, ST. LOUIS, MO, 63101
- Phone: 314-787-7475
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Francis M Creighton | Director | St. Louis, MO |
| Eric A Gulve | Director | St. Louis, MO |
| Thomas J Hillman | Director | Saint Louis, MO |
| Bevil J Hogg | Director | St. Louis, MO |
| Stephen A Wexler | Director | St. Louis, MO |
| Francis M Creighton | Executive Officer | St. Louis, MO |
| Sean A Morris | Executive Officer | St. Louis, MO |
| Peggy A Stohr | Executive Officer | St. Louis, MO |
| Sean Morris | Director | Wildwood, MO |
| Sean Morris | Executive Officer | Wildwood, MO |
| James C Wachtman | Executive Officer | KANSAS CITY, MO |
| Thomas Hillman | Director | Saint Louis, MO |
| Eric Moessinger | Director | San Francisco, CA |
| PEGGY STOHR | Executive Officer | ST. LOUIS, MO |
| Daniel J Broderick | Director | Durham, NC |
| PETER S FINLEY | Executive Officer | CLAYTON, MO |
| Rogers A Ritter | Executive Officer | St. Louis, MO |
| Amy L Boyet | Executive Officer | St. Louis, MO |
| Rogers M Ritter | Executive Officer | St. Louis, MO |
Other filings by this issuer (4)
More